{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:59:41Z","timestamp":1785376781171,"version":"3.55.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,2,1]],"date-time":"2005-02-01T00:00:00Z","timestamp":1107216000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2005,2]]},"DOI":"10.1136\/ard.2004.023119","type":"journal-article","created":{"date-parts":[[2004,7,2]],"date-time":"2004-07-02T00:16:40Z","timestamp":1088727400000},"page":"303-305","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":175,"title":["Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis"],"prefix":"10.1016","volume":"64","author":[{"given":"C","family":"Popa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M G","family":"Netea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J W M","family":"Van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A F H","family":"Stalenhoef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P L C M","family":"van Riel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Barerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 3","key":"10.1136\/ard.2004.023119_bib1","doi-asserted-by":"crossref","first-page":"S462","DOI":"10.1086\/315611","article-title":"Infection and inflammation-induced proatherogenic changes of lipoproteins","volume":"181","author":"Khovidhunkit","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1136\/ard.2004.023119_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/1043-2760(91)90027-K","article-title":"Tumour necrosis factor, cytokines and the hyperlipidemia of infection","volume":"6","author":"Grunfeld","year":"1991","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1136\/ard.2004.023119_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/0003-4819-121-9-199411010-00002","article-title":"Cholesterol and coronary heart disease: predicting risks by levels and ratios","volume":"121","author":"Kinosian","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.2004.023119_bib4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/art.10089","article-title":"Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis?","volume":"46","author":"Van","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.023119_bib5","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1002\/art.10359","article-title":"Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound","volume":"46","author":"Park","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.2004.023119_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1161\/01.CIR.0000053730.47739.3C","article-title":"Clinical application of C-reactive protein for cardiovascular disease detection and prevention","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1136\/ard.2004.023119_bib7","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/rheumatology\/41.6.658","article-title":"Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis","volume":"41","author":"van","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2004.023119_bib8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1136\/ard.2004.023119_bib9","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/rheumatology\/41.4.430","article-title":"Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumor necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis","volume":"41","author":"Barrera","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/ard.2004.023119_bib10","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/clinchem\/43.4.663","article-title":"Precipitation methods for high-density lipoprotein cholesterol measurement compared, and final evaluation under routine operating conditions of a method with a low sample to reagent ratio","volume":"43","author":"Demacker","year":"1997","journal-title":"Clin Chem"},{"key":"10.1136\/ard.2004.023119_bib11","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1200\/JCO.1988.6.2.344","article-title":"ecombinant human tumor necrosis factor administered as a five-day continous infusion in cancer patients: phase I toxicity and effects on lipid metabolism","volume":"6","author":"Sherman","year":"1988","journal-title":"J Clin Oncol"},{"key":"10.1136\/ard.2004.023119_bib12","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1161\/01.CIR.0000037521.71373.44","article-title":"Anti-tumour necrosis factor-\u03b1 treatment improves endothelial function in patients with rheumatoid arthritis","volume":"106","author":"Hurlimann","year":"2002","journal-title":"Circulation"},{"key":"10.1136\/ard.2004.023119_bib13","first-page":"1004","article-title":"Intravenous anti-TNF-\u03b1 antibody therapy leads to elevated triglyceride and reduced HDL-cholesterol levels in patients with rheumatoid and psoriatic arthritis","volume":"114","author":"Cauza","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"10.1136\/ard.2004.023119_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(02)08213-2","article-title":"Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study","volume":"359","author":"Choi","year":"2002","journal-title":"Lancet"},{"key":"10.1136\/ard.2004.023119_bib15","first-page":"S241","article-title":"Low incidence of first cardiovascular event in rheumatoid arthritis patients treated with TNF-blockers [abstract]","volume":"48","author":"Jacobsson","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724431464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724431464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.2004.023119","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T05:27:53Z","timestamp":1736141273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724431464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,2]]}},"alternative-id":["S0003496724431464"],"URL":"https:\/\/doi.org\/10.1136\/ard.2004.023119","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2005,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.2004.023119","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Copyright 2005 by Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}